Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Understand the reasons for choosing a retirement plan over a 401k. Make informed decisions for a secure retirement.
23,531 articlesA dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Investors are split as talks on a possible Iran accord fuel optimism and a warning that the iran deal could actually ...
CONL sinks 67% year to date as COIN slides 33%, underscoring the volatility tax embedded in daily-reset leveraged ETF...
As AI demand drives 24/7 data-center power, investors pivot from solar bets to nuclear plays. The nuclear fund is del...
The INDS ETF blends self-storage and warehouse assets to offer a roughly 3.5% yield, presenting a mixed exposure that...
ASML Holdings rode a broad wave of positive signals in June, even without a fresh earnings release. This article brea...
U.S. savers are seeing a wave of HYSA promotions with big headline yields that may fade after a short window. This pi...
The SPDR S&P Retail ETF has posted double-digit gains over the last year, yet leaders emerge among value-focused reta...
Bitcoin staged a striking break from a long-standing pattern, defying a rising dollar as ETF inflows surged. Analysts...
Federal actions against a Coca-Cola bottler and an EEOC inquiry into Nike signal a broader shift in how discriminatio...
Scotiabank boosted Cameco's price target to $175 as a global push for nuclear power gains traction and a new supply d...
Ripple vaults onto CNBC’s disruptor list, while XRP trades in a tight range. The token hovered around $1.35 as market...